Fibroblast growth factor 21 ameliorates psoriasiform inflammation and epidermal hyperplasia through the regulation of NF-κB and autophagy pathways
- 25 May 2026
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 184, 116904
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Zhejiang Province (Y201942205)
- Department of Education of Zhejiang Province (Y201942205)
- National Natural Science Foundation of China (81101570)
- Wenzhou Municipal Science and Technology Bureau (Y2020146)
This publication has 64 references indexed in Scilit:
- Kaempferol suppresses TLR-2 and TLR-4 coactivation by attenuation of LPS/LTA-induced inflammation and cellular stressMolecular Biology Reports, 2025
- Pathophysiology, Clinical Presentation, and Treatment of PsoriasisJAMA, 2020
- Role of Silent Information Regulator 1 (SIRT1) in Regulating Oxidative Stress and InflammationInflammation, 2020
- Keratinocyte: A trigger or an executor of psoriasis?Journal of Leukocyte Biology, 2020
- Cell death: a review of the major forms of apoptosis, necrosis and autophagyCell Biology International, 2019
- PI3K/AKT/mTOR activation and autophagy inhibition plays a key role in increased cholesterol during IL-17A mediated inflammatory response in psoriasisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2018
- Healthcare Databases for Drug Safety Research: Data Validity Assessment Remains CrucialDrug Safety, 2018
- FGF21 exerts comparable pharmacological efficacy with Adalimumab in ameliorating collagen-induced rheumatoid arthritis by regulating systematic inflammatory responseBiomedicine & Pharmacotherapy, 2017
- The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes studyDiabetologia, 2014
- Autophagy and apoptosis: where do they meet?Apoptosis, 2014